[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2]. [PDF]
Reina J.
europepmc +1 more source
[Frequency of cutaneous drug reactions in the outpatient dermatology clinic at the National Institute of Cardiology Ignacio Chávez over a ten-year period]. [PDF]
Coria-Vázquez S +5 more
europepmc +1 more source
[SARS-Cov-2 vaccination and metabolic radionuclide therapy: document of the SEMNIM Endocrinology Working Group]. [PDF]
Negre Busó M +3 more
europepmc +1 more source
[The relevant role of caregivers of patients using opioid analgesics]. [PDF]
Hernández-García V +3 more
europepmc +1 more source
[Pharmacological treatment of type 2 diabetes mellitus]. [PDF]
García Soidán FJ +1 more
europepmc +1 more source
[Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir]. [PDF]
Brandariz-Nuñez D +5 more
europepmc +1 more source
[Impact of P-CABs in the Treatment of Acid-related Diseases: an Evidence Review]. [PDF]
Remes-Troche JM +2 more
europepmc +1 more source
[MUR and MCA: allies to guarantee therapeutic success]. [PDF]
Díaz López C.
europepmc +1 more source

